Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03913715 · ClinicalTrials.gov registry record · NA

Ostomy Rural Telehealth Training Cancer Survivors

A NA study of Quality of Life and Ostomy, sponsored by Abramson Cancer Center at Penn Medicine.

Active
Registry status
NA
Development phase
204
Enrollment target
10
Study locations

NCT03913715 is a NA study of Quality of Life and Ostomy that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 204 participants, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (55% lower). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03913715, a NA study of Quality of Life and Ostomy, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
10
Study locations

Study Summary

Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 43,030 rectal cancer cases and 81,190 bladder cancer cases will be diagnosed in 2018.Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointestinal, or other gastro-urinary tumors. The health-related quality of life impact is tremendous and greater than with many other cancer treatments. An ostomy is often a prolonged or lifelong disabling problem for cancer survivors. The adaptation period is quite variable. In our R01 study, 18% of participants took at least one year to be comfortable, or never felt comfortable, in managing their ostomy care. Importantly, many patients cannot attend in-person self-management programs or patient groups for a myriad of reasons, including distance to travel, lack of access to transportation, monetary outlays, competing demands (such as work), or comorbidities making travel difficult. In addition, a national shortage of OCNs means patients with an ostomy, whether newly placed or a long-term issue, receive little help. It is imperative to study interventions for rural survivors aimed to limit family financial burdens, improve ostomy outcomes, and improve survivors' well-being.

Interventions

  • OTHER Ostomy Self-Management Training

Study Locations (10)

Pennsylvania

  • Geisinger - Danville
  • Lancaster General Hospital - Lancaster
  • Penn Medicine - Philadelphia

California

  • City Of Hope - Duarte
  • Loma Linda University Health - Loma Linda

Arkansas

  • University of Arkansas For Medical Sciences - Little Rock

New Mexico

  • University of New Mexico - Albuquerque

North Carolina

  • University of North Carolina - Chapel Hill

North Dakota

  • Sanford Research Center - Fargo

South Carolina

  • University of South Carolina Greenville (Prisma Health) - Greenville

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2019-08-01
Est. Completion 2026-10-31
Phase NA

What the Registry Record Tells You About NCT03913715

The ClinicalTrials.gov registry entry for NCT03913715 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 107 other Quality of Life trials with a reported enrollment target (55% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Ostomy Self-Management Training is the first listed.

NCT03913715 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Pennsylvania, California, Arkansas.

Frequently Asked Questions

What is clinical trial NCT03913715 about?

NCT03913715 is a clinical study titled "Ostomy Rural Telehealth Training Cancer Survivors". Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 43,030 rectal cancer cases and 81,190 bladder cancer cases will be diagnosed in 2018.Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointesti...

What is the current status of trial NCT03913715?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2019-08-01. Estimated completion is 2026-10-31.

What conditions does trial NCT03913715 study?

This clinical trial studies the following conditions: Quality of Life, Ostomy, Telehealth.

What interventions are being tested in trial NCT03913715?

The interventions under investigation include: Ostomy Self-Management Training (OTHER).

Who is sponsoring clinical trial NCT03913715?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03913715 being conducted?

This trial has 10 study locations across Arkansas, California, New Mexico, North Carolina, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.